AndreaBozzo/ceres-open-data-index huggingface dataset:
MD COVID-19 Total Currently Hospitalized Adult and Pediatric Acute and ICU

<b>NOTE:</b> This dataset is no longer being updated as of 4/27/2023.
It is retired and no longer included in public COVID-19 data dissemination.

See this link for more information
https://imap.maryland.gov/pages/covid-data

<b>Summary</b>

The daily occupancy number of COVID-19 designated hospital beds in Maryland.

<b>Description</b>

The MD COVID-19 - Total Currently Hospitalized - Acute and ICU data layer is a collection of the statewide cumulative total of individuals who tested positive for COVID-19 that have been reported each day via CRISP as currently occupying a COVID-19 bed in a Maryland hospital facility. MD COVID-19 - Total Currently Hospitalized comprises four subsets: Adult Acute Care Beds, Adult ICU Beds Pediatrics Acute Care Beds and Pediatrics ICU Care Beds.

<b>Terms of Use</b>

The Spatial Data, and the information therein, (collectively the "Data") is provided "as is" without warranty of any kind, either expressed, implied, or statutory. The user assumes the entire risk as to quality and performance of the Data. No guarantee of accuracy is granted, nor is any responsibility for reliance thereon assumed. In no event shall the State of Maryland be liable for direct, indirect, incidental, consequential or special damages of any kind. The State of Maryland does not accept liability for any damages or misrepresentation caused by inaccuracies in the Data or as a result to changes to the Data, nor is there responsibility assumed to maintain the Data in any manner or form. The Data can be freely distributed as long as the metadata entry is not modified or deleted. Any data derived from the Data must acknowledge the State of Maryland in the metadata.
Compound 525435: 3,5-Dithia-1-octene

Chemical compound data from PubChem database. IUPAC Name: 1-(ethenylsulfanylmethylsulfanyl)propane. Molecular Formula: C6H12S2. Molecular Weight: 148.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401435-T1: [Translated] USE OF A CELLULOSIC FIBER OF THE LYOCELL GENUS

Chemical patent from PubChem database. Patent Number: AT-E401435-T1. Title: Pharmaceutical Salt Forms. Filing Date: 2006-03-11. Inventors: Chen, Wei, Kumar, Raj, Williams, Sarah. Abstract: Novel pharmaceutical salt forms are provided, exhibiting improved physicochemical properties including enhanced solubility, stability, and bioavailabi... IPC Classifications: C08G, C08K, A61K. This patent covers 45 claims related to 4 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.
Flow cytometry analysis of the effect of allopurinol and the dinitroaniline compound (Chloralin) on the viability and proliferation of

Background
          Leishmaniasis is a major parasitic disease in the tropical regions. However, Leishmania infantum has recently emerged as a very important cause of opportunistic infections for individuals positive for human immunodeficiency virus (HIV). However, there is a lack of in vitro tests for assessing the effect of anti-parasitic drugs on the viability and proliferation of Leishmania infantum. The aim of this study is to assess the efficacy of anti-parasitic drugs like allopurinol and Chloralin on the viability and proliferation of L. infantum promastigotes by utilizing two complementary flow cytometric approaches after exposure of the promastigotes to various concentrations of the drugs.
        
        
          Results
          The density of the cultures in the presence and absence of allopurinol was determined by haemocytometer enumeration. The two flow cytometric approaches used to monitor the drug effect were: (i) a quantitative method to measure cell division using 5-,6-carboxyfluorescein diacetate succinimidyl ester (CFSE) staining and (ii) evaluation of cell viability by dual-staining with the membrane-permeable nuclear stain, SBRY-14 and propidium iodide. It was found that concentrations of allopurinol above 50 μg/ml yielded a clear decrease in the proliferation rate of the promastigotes. However, the viability results showed that about 46.8% of the promastigotes incubated in the presence of 800 μg/ml of allopurinol were still alive after 96 hours. In sharp contrast, more than 90% of promastigotes treated with Chloralin 10 μM (2.7 μg/ml) were dead after 48 hours of treatment. These flow cytometric findings suggest that allopurinol has a leishmaniostatic effect while the dinitroaniline compound (Chloralin) has a leishmaniocidal effect against promastigotes.
        
        
          Conclusions
          The flow cytometric data on proliferation and viability were consistent with results obtained from haemocytometer counts and allowed us to develop a model for assessing in vitro the effects of medicaments like allopurinol and chloralin on L. infantum promastigotes on a cellular level.
Compound 530448: 4-Butylbenzoic acid, 2-(1-adamantyl)ethyl ester

Chemical compound data from PubChem database. IUPAC Name: 2-(1-adamantyl)ethyl 4-butylbenzoate. Molecular Formula: C23H32O2. Molecular Weight: 340.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Hospital-Acquired Condition (HAC) Reduction Program

Hospital-Acquired Condition (HAC) Reduction Program (HACRP) - In October 2014, CMS began reducing Medicare fee-for-service payments for subsection (d) hospitals that rank in the worst-performing quartile with respect to hospital-acquired condition (HAC) quality measures. Hospitals with a Total HAC Score above the 75th percentile of the Total HAC Score distribution will be subject to a 1-percent payment reduction. This table contains hospitals' measure and Total HAC scores. The Total HAC Score is calculated as the equally weighted average of hospitals' individual measure scores.
2014 National Survey on Drug Use and Health:  Methodological Summary and Definitions

This report summarizes methods and other supporting information that are relevant to estimates of substance use and mental health issues from the 2014 National Survey on Drug Use and Health (NSDUH), an annual survey of the civilian, noninstitutionalized population of the United States aged 12 years old or older. This report is organized into six sections. Section A describes the survey, including information about the sample design, data collection procedures, and key aspects of data processing (e.g., development of analysis weights). Section B presents technical details on the statistical methods and measurement, such as suppression criteria for unreliable estimates, statistical testing procedures, and issues for selected substance use and mental health measures. A glossary that covers key definitions used in NSDUH reports and tables is included in Section C. Section D describes other sources of data on substance use and mental health issues, including data sources for populations outside the NSDUH target population. A list of references cited in the report (Section E) and contributors to this report (Section F) also are provided.
Table 26. Had Serious Thoughts of Suicide in the Past Year among Persons Aged 18 or Older, by State and Substate Regions: Percentages, Annual Averages Based on 2008, 2009, and 2010 NSDUHs

This table presents the 2008 to 2010 National Survey on Drug Use and Health (NSDUH) estimates of past year serious thoughts of suicide among those aged 18 or older by State and substate regions.
Compound 525584: N,N-Dimethyl-N'-(3-nitrophenyl)-p-methoxybenzamidine

Chemical compound data from PubChem database. IUPAC Name: 4-methoxy-N,N-dimethyl-N'-(3-nitrophenyl)benzenecarboximidamide. Molecular Formula: C16H17N3O3. Molecular Weight: 299.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Impact of nosocomial pneumonia on the outcome of mechanically-ventilated patients

Background:
          Nosocomial pneumonia (NP) is a common complication in mechanically-ventilated patients and is considered to be one of the most common causes of morbidity and mortality. However, assessment of the associated mortality is not staightforward as it shares several risk factors with NP that confound the relationship. The aim of this study was to evaluate the impact of NP on the mortality rate in an intensive care unit. During the study period (January-December 1995) all patients under mechanical ventilation for a period > 48 h (n = 314) were prospectively evaluated, and the prognostic factors of NP, which have been identified in previous studies, were recorded.
        
        
          Results:
          Pneumonia was diagnosed in 82 patients. The overall mortality rate was 34% for patients with NP compared to 17% in those without NP. Multivariate analysis selected the following three prognostic factors as being significantly associated with a higher risk of death: the presence of multiple organ failure [odds ratio (OR) 6.71, 95% CI, P < 0.001]; the presence of adult respiratory distress syndrome (ARDS) (OR 3.03, 95% CI, P < 0.01), and simplified acute physiology score (SAPS)> 9(OR 2.89, 95% CI, P < 0.05).
        
        
          Conclusions:
          In mechanically-ventilated patients NP does not represent an independent risk factor for mortality. Markers of severity of illness were the strongest predictors for mortality.
Program Instruction (PI-15-04)

This Program Instruction (PI) provides instruction to Tribes on the June 30, 2015, submission of: (1) the Annual Progress and Services Report (APSR) required under Title IV-B of the Social Security Act (the Act) for the Stephanie Tubbs Jones Child Welfare Services and Promoting Safe and Stable Families (PSSF) Programs; the Chafee Foster Care Independence Program (CFCIP); and the Education and Training Vouchers (ETV) Program; and (2) the CFS-101, Part I, Annual Budget Request; Part II, Annual Summary of Child and Family Services; and Part III, Annual Expenditure Report—Title IV-B, subparts 1 and 2, CFCIP, and ETV, as applicable.

PI-15-04 (PDF)

Fiscal Year 2015 Allotment Title IV-B, Subpart 1 Stephanie Tubbs Jones Child Welfare Services
Fiscal Year 2015 Allotment Title IV-B, Subpart 2 - Promoting Safe and Stable Families
Fiscal Year 2015 Chafee Foster Care Independence Program and Education and Training Voucher Program

CFS-101 Part I:  Annual Budget Request for Title IV-B, Subparts 1 and 2, CAPTA, Chafee Foster Care Independence (CFCIP) and Education and Training Voucher (ETV) Program Instructions
CFS-101 Part I:  Annual Budget Request for Title IV-B, Subparts 1 and 2, CAPTA, Chafee Foster Care Independence (CFCIP) and Education and Training Voucher (ETV) Program Form (Excel (XLSX) - 15 KB)
CFS-101, Part II: Annual Summary of Child and Family Services Instructions
CFS-101, Part II: Annual Summary of Child and Family Services Form (Excel (XLSX) - 15 KB)
CFS-101, Part III: Annual Expenditures for Title IV-B, Subparts 1 and 2, CAPTA, Chafee Foster Care Independence (CFCIP) and Education and Training Voucher (ETV) Instructions
CFS-101, Part III: Annual Expenditures for Title IV-B, Subparts 1 and 2, CAPTA, Chafee Foster Care Independence (CFCIP) and Education and Training Voucher (ETV) Form (Excel (XLSX) - 14 KB)

Children’s Bureau Regional Program Managers

Metadata-only record linking to the original dataset. Open original dataset below.
Cumulative Influenza Vaccination Coverage by Race/Ethnicity and Age Group, NIS-ACM

Cumulative Influenza Vaccination Coverage Age Group, Race/Ethnicity, and Jurisdiction, Adults 18 Years and Older, United States, National Immunization Survey Adult COVID Module.

Archived data are available including for Figures 4B and 4C:  https://data.cdc.gov/resource/8dyx-9z99 

•  The National Immunization Survey-Adult COVID Module (NIS-ACM) was launched in April 2021 among adults 18 years and older. The survey was used to monitor COVID-19 vaccination uptake and confidence in vaccination among adults and included questions about influenza vaccination.
Compound 525916: 4-Hydroxypiperitone

Chemical compound data from PubChem database. IUPAC Name: 4-hydroxy-5-methyl-2-propan-2-ylcyclohexan-1-one. Molecular Formula: C10H18O2. Molecular Weight: 170.25. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526837: 12-Hydroxy-nonadecanoic, methyl ester, tBDMS ether

Chemical compound data from PubChem database. IUPAC Name: methyl 12-[tert-butyl(dimethyl)silyl]oxynonadecanoate. Molecular Formula: C26H54O3Si. Molecular Weight: 442.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Sample size requirements for case-control study designs

Background
          Published formulas for case-control designs provide sample sizes required to determine that a given disease-exposure odds ratio is significantly different from one, adjusting for a potential confounder and possible interaction.
        
        
          Results
          The formulas are extended from one control per case to F controls per case and adjusted for a potential multi-category confounder in unmatched or matched designs. Interactive FORTRAN programs are described which compute the formulas. The effect of potential disease-exposure-confounder interaction may be explored.
        
        
          Conclusions
          Software is now available for computing adjusted sample sizes for case-control designs.
COVID-19 State Profile Report - New York

<b>After over two years of public reporting, the State Profile Report will no longer be produced and distributed after February 2023. The final release was on February 23, 2023. We want to thank everyone who contributed to the design, production, and review of this report and we hope that it provided insight into the data trends throughout the COVID-19 pandemic.
Data about COVID-19 will continue to be updated at <a href='https://covid.cdc.gov/covid-data-tracker/#datatracker-home' >CDC’s COVID Data Tracker</a>.
 </b>

<p>
The State Profile Report (SPR) is generated by the Data Strategy and Execution Workgroup in the Joint Coordination Cell, in collaboration with the White House. It is managed by an interagency team with representatives from multiple agencies and offices (including the United States Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention, the HHS Assistant Secretary for Preparedness and Response, and the Indian Health Service). The SPR provides easily interpretable information on key indicators for each state, down to the county level.
 </p>

It is a weekly snapshot in time that:
<ul>
<li>Focuses on recent outcomes in the last seven days and changes relative to the month prior</li>
<li>Provides additional contextual information at the county level for each state, and includes national level information</li>
<li>Supports rapid visual interpretation of results with color thresholds</li>
</ul>
Compound 529451: Guaia-1(10),11-dien-15,2-olide

Chemical compound data from PubChem database. IUPAC Name: 2,6-dimethyl-10-methylidene-4-oxatricyclo[5.4.1.13,11]tridec-1-en-5-one. Molecular Formula: C15H20O2. Molecular Weight: 232.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400196-T1: [Translated] PROTECTIVE CLOTHING, CONSISTING AT LEAST PARTLY OF A METAL RING MESH, WITH DETACHABLE STIFFENING MEANS

Reinforcing strips (10) for an avoidance of collapsing are accommodated in pockets (11) positioned at the outer surface of the gauntlet. The strip (10) is inserted through an opening (13) at the upper edge of the glove and a flap (12) pulled over its upper end. The flap (12) is fastened with a suitable device (14) which can be a screw. The strip (10) can be removed for cleaning or for being replaced.
Compound 527816: 2-(4-Ethylphenyl)propionic acid

Chemical compound data from PubChem database. IUPAC Name: 2-(4-ethylphenyl)propanoic acid. Molecular Formula: C11H14O2. Molecular Weight: 178.23. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
National Estimates of Drug-Related Emergency Department Visits, 2004-2011 - Adverse Reactions

Excel file with national estimates, rates, relative standard errors, trends and confidence intervals, covering 2004-2011 for emergency department visits involving adverse reactions.  It includes ED visits in which an adverse health consequence (e.g., side effects or an allergic reaction) resulted when taking prescription drugs, over-the-counter medications, or dietary supplements as prescribed or recommended.  This analytic category does not include drug misuse or abuse.File includes data for over 500 drugs, including illicit drugs, prescription and over-the-counter medications, dietary supplements, inhalants and alcohol.  Includes total visits, gender, age group, race/ethnicity, outcome of visit, drug combinations, number of drugs involved in visit, drug frequency, and drugs confirmed by toxicology.Additional detail is provided for illicit drugs, psychotherapeutic drugs, central nervous system (CNS) drugs, respiratory drugs and cardiovascular drugs.
Table 25. Any Mental Illness in the Past Year among Persons Aged 18 or Older, by State and Substate Regions: Percentages, Annual Averages Based on 2010, 2011, and 2012 NSDUHs

Table 25. Any Mental Illness in the Past Year among Persons Aged 18 or Older, by State and Substate Regions: Percentages, Annual Averages Based on 2010, 2011, and 2012 NSDUHs
Telemedicine Use in the Last 4 Weeks

To rapidly monitor recent changes in the use of telemedicine, the National Center for Health Statistics (NCHS) and the Health Resources and Services Administration’s Maternal and Child Health Bureau (HRSA MCHB) partnered with the Census Bureau on an experimental data system called the Household Pulse Survey. This 20-minute online survey was designed to complement the ability of the federal statistical system to rapidly respond and provide relevant information about the impact of the coronavirus pandemic in the U.S.

The U.S. Census Bureau, in collaboration with five federal agencies, launched the Household Pulse Survey to produce data on the social and economic impacts of the COVID-19 pandemic on American households.  The Household Pulse Survey was designed to gauge the impact of the pandemic on employment status, consumer spending, food security, housing, education disruptions, and dimensions of physical and mental wellness.

The survey was designed to meet the goal of accurate and timely estimates. It was conducted by an internet questionnaire, with invitations to participate sent by email and text message. The sample frame is the Census Bureau Master Address File Data. Housing units linked to one or more email addresses or cell phone numbers were randomly selected to participate, and one respondent from each housing unit was selected to respond for him or herself. Estimates are weighted to adjust for nonresponse and to match Census Bureau estimates of the population by age, sex, race and ethnicity, and educational attainment. All estimates shown meet the NCHS Data Presentation Standards for Proportions.
Compound 528853: 5,7-Diethyl-1,2,3,4,6-pentathiepane

Chemical compound data from PubChem database. IUPAC Name: 5,7-diethyl-1,2,3,4,6-pentathiepane. Molecular Formula: C6H12S5. Molecular Weight: 244.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Managed Care Individual Provider Network Data: September 30, 2017

The primary purpose for the Provider Network Data System is to collect data needed to evaluate the provider networks including physicians, hospitals, labs, home health agencies, durable medical equipment providers, etc., for all types of health plans in New York State. Beginning in 2017, the PNDS includes Medicaid Managed Care (MMC), HIV Special Need Plans (SNP), Health and Recovery Plans (HARP), Child Health Plus (CHP), Programs of All-Inclusive Care for the Elderly (PACE), Non-PACE Managed Long-Term Care (MLTC) plans, Qualified Health Plans (QHP), Essential Plans (EP), and commercial plans (commercial plan reporting will be incomplete until Q2 2017). This dataset reflects individual provider data. Provider Network Data System information is self-reported by health plans. The PNDS data dictionary can be found at http://www.health.ny.gov/health_care/managed_care/docs/dictionary.pdf . To use the NYS Provider & Health Plan Look-Up Tool, click on the following link, https://pndslookup.health.ny.gov/ .
Patent AT-E399970-T1: [Translated] SUN RECEIVER WITH MULTIPLE ENTRY OPENINGS FOR THE WORKING MEDIUM

A solar receiver ( 2 ) comprises a housing ( 4 ) defining a receiver chamber ( 12 ) and an aperture ( 14 ); a window ( 16 ) mounted in the aperture ( 14 ); at least two inlet means ( 17 ) axially spaced from the window ( 16 ) and positioned at different distances therefrom for the injection into the receiver chamber ( 12 ) of different flows of workind fluid; an outlet means ( 18 ) for the ejection of the working fluid out of the receiver chamber ( 12 ); and absorption control means for the provision of the different flows of the working fluid with different capability to absorb solar radiation
MICE, a program to track and monitor animals in animal facilities

Background
          A growing number of laboratories are using the mouse as a model system in developmental biology as well as in molecular biology. Surprisingly, most of these laboratories do not have reliable computerized systems to track these animals, and the few commercial solutions available are expensive. We thus developed MICE (Mouse Information and Classification Entity), a program aimed at facilitating the monitoring of animals in animal facilities.
        
        
          Results
          This program consists of a virtual facility in which scientists can perform all the tasks done in the real world (i.e., receiving animals, breeding them, preparing cage labels, etc.). Recording of each animal (birth date, cage number, ID number, tail analysis number, parents, genetic status, genetic background, etc.) enables reliable tracking. According to any parameter of interest, animals can then be identified, grouped, sorted, moved, and so forth. Crossings are automatically processed by the program. For example, new genetic backgrounds, generation number, and anticipated due dates are determined. The program also reminds the user when new births are expected and entering newborn animals only requires a few clicks. The genealogy of each animal can be determined in two different ways, one being the visualization of a genealogical tree from which information of ancestors can be retrieved.
        
        
          Conclusion
          This standalone program, that will be distributed free of charge to academic laboratories requesting a license, represents a new and valuable tool for all animal facility users, and permits simple and reliable tracking and retrieving of animals.
Compound 526391: 1-Bromo,2,3,6-trichloro-dibenzo-dioxin

Chemical compound data from PubChem database. IUPAC Name: 1-bromo-2,3,6-trichlorodibenzo-p-dioxin. Molecular Formula: C12H4BrCl3O2. Molecular Weight: 366.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.